Is JSPR or KYTX more undervalued in 2026?

CirclFi compares Jasper Therapeutics, Inc. (JSPR) and Kyverna Therapeutics, Inc. (KYTX) using 13 institutional-grade valuation models. JSPR has a Quality of Company score of 3.5/10 while KYTX scores 4.2/10.

Which is a better buy — JSPR or KYTX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do JSPR and KYTX valuations compare?

JSPR at $0.83 and KYTX at $8.52 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

JSPR vs KYTX Valuation Comparison 2026 — Intrinsic Value Analysis

JSPR

Biological Products, (No Diagnostic Substances)

Jasper Therapeutics, Inc.

Quality

3.5

out of 10

Value Trap

LOW

Price

$0.83

Last close

Models

7/13

Active

KYTX

Biological Products, (No Diagnostic Substances)

Kyverna Therapeutics, Inc.

Quality

4.2

out of 10

Value Trap

SAFE

Price

$8.52

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	JSPR Fair Value	JSPR Upside	KYTX Fair Value	KYTX Upside
Bayesian DCF	Intrinsic	$0.48	-42.0%	$2.40	-71.8%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.03	-96.7%	$2.70	-68.3%
Dynamic NAV	Asset-Based	$2.18	+163.1%	$3.58	-57.9%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for JSPR vs KYTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

JSPR vs KYTX — Which Stock Is More Undervalued?

KYTX scores higher with a 4.2/10 quality rating vs JSPR's 3.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Jasper Therapeutics, Inc. (JSPR) and Kyverna Therapeutics, Inc. (KYTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

JSPR currently trades at $0.83 with a QOC of 3.5/10, while KYTX trades at $8.52 with a QOC of 4.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).